IMPALA MOL-PAP-002 A randomised double blind placebo controlled multicentre clinical trial of inhaled molgramostim in autoimmune pulmonary alveolar proteinosis patients

Administered By

Awarded By

Contributors

Start/End

  • August 21, 2018 - December 17, 2019